BCAX
Bicara Therapeutics Inc.
22.00$
-2.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +3,390.7% | +143.3% | -24.3% | |
| – | +4,536.3% | +117.5% | -16.0% | |
| – | +5,442.1% | +112.5% | -80.3% | |
| – | +5,442.1% | +112.5% | -15.3% | |
| – | -35.5% | +399.7% | -61.8% | |
| – | -36.9% | +19.3% | +60.9% | |
| – | – | +113.0% | +84.0% | |
| – | -38.0% | +41.5% | +72.9% | |
| – | – | +125.1% | -18.4% | |
| – | – | – | – | |
| – | +0.0% | +5.1% | +0.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.